Victory Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-9,499
| Closed | -$227K | – | 2852 |
|
|
2021
Q1 | $227K | Sell |
9,499
-12,823
| -57% | -$238K | ﹤0.01% | 2494 |
|
|
2020
Q4 | $326K | Sell |
22,322
-15,552
| -41% | -$206K | ﹤0.01% | 2256 |
|
|
2020
Q3 | $538K | Buy |
37,874
+12,529
| +49% | +$191K | ﹤0.01% | 1928 |
|
|
2020
Q2 | $373K | Buy |
25,345
+10,427
| +70% | +$106K | ﹤0.01% | 2092 |
|
|
2020
Q1 | $62K | Buy |
+14,918
| New | +$69.9K | ﹤0.01% | 2686 |
|
|
2019
Q4 | – | Sell |
-6,880
| Closed | -$42K | – | 3603 |
|
|
2019
Q3 | $42K | Buy |
+6,880
| New | +$42.9K | ﹤0.01% | 2763 |
|
|
2019
Q1 | – | Sell |
-7,413
| Closed | -$36K | – | 1908 |
|
|
2018
Q4 | $36K | Hold |
7,413
| – | – | ﹤0.01% | 1715 |
|
|
2018
Q3 | $54K | Buy |
7,413
+974
| +15% | +$7.15K | ﹤0.01% | 1723 |
|
|
2018
Q2 | $41K | Hold |
6,439
| – | – | ﹤0.01% | 1769 |
|
|
2018
Q1 | $35K | Hold |
6,439
| – | – | ﹤0.01% | 1774 |
|
|
2017
Q4 | $27K | Hold |
6,439
| – | – | ﹤0.01% | 1775 |
|
|
2017
Q3 | $62K | Hold |
6,439
| – | – | ﹤0.01% | 1733 |
|
|
2017
Q2 | $76K | Buy |
6,439
+110
| +2% | +$1.41K | ﹤0.01% | 1706 |
|
|
2017
Q1 | $81K | Hold |
6,329
| – | – | ﹤0.01% | 1685 |
|
|
2016
Q4 | $77K | Buy |
6,329
+352
| +6% | +$4.18K | ﹤0.01% | 1636 |
|
|
2016
Q3 | $71K | Buy |
5,977
+399
| +7% | +$3.85K | ﹤0.01% | 1647 |
|
|
2016
Q2 | $49K | Buy |
5,578
+219
| +4% | +$1.5K | ﹤0.01% | 1520 |
|
|
2016
Q1 | $28K | Buy |
5,359
+415
| +8% | +$2.31K | ﹤0.01% | 1580 |
|
|
2015
Q4 | $38K | Buy |
4,944
+274
| +6% | +$2.1K | ﹤0.01% | 1605 |
|
|
2015
Q3 | $37K | Buy |
4,670
+358
| +8% | +$3.31K | ﹤0.01% | 1550 |
|
|
2015
Q2 | $39K | Buy |
+4,312
| New | +$43.5K | ﹤0.01% | 1556 |
|
Victory Capital Management's GNMK Position: Q2 2021 in Review
Victory Capital Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 9,499 shares — an estimated $227K sold.
Victory Capital Management first reported a position in GNMK in Q2 2015 and held it in 21 quarters. The position peaked at $538K in Q3 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Victory Capital Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Victory Capital Management sold 9,499 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $227K.
- Victory Capital Management first reported a position in GenMark Diagnostics, Inc in Q2 2015 and held it in 21 quarters.
- Victory Capital Management's GenMark Diagnostics, Inc position peaked at $538K in Q3 2020.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Victory Capital Management's 13F filing for Q2 2021, filed 3 Aug 2021.